Publication Name	World Journal of Diabetes
Manuscript ID	92914
Country	Spain

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease
Manuscript Source	Invited Manuscript
All Author List	Javier Donate-Correa, Ainhoa González-Luis, Jésica Díaz-Vera and Juan Ramón Hernandez-Fernaud
Funding Agency and Grant Number
Corresponding Author	Javier Donate-Correa, PhD, Research Scientist, Teacher, Research Unit, University Hospital Nuestra Señora de Candelaria (UHNSC), Carretera del Rosario S/N, Santa Cruz de Tenerife 38010, Spain. jdonatecorrea@gmail.com
Key Words	Diabetes; Diabetic kidney disease; Inflammation; Toll-like receptor 4; microRNA-630
Core Tip	Targeting Toll-like receptors (TLRs) via microRNAs is a promising therapeutic approach for reducing inflammation and slowing the progression of diabetic kidney disease (DKD). Understanding how TLR4 expression and signaling are linked to microRNAs regulation, may pave the path for future targeted clinical interventions in DKD.
Citation	Donate-Correa J, González-Luis A, Díaz-Vera J, Hernandez-Fernaud JR. MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease . World J Diabetes 2024; In press

Received	2024-02-10 16:49
Peer-Review Started	2024-02-10 16:49
To Make the First Decision
Return for Revision	2024-03-05 02:55
Revised	2024-03-18 15:21
Second Decision	2024-04-22 02:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-04-22 06:16
Articles in Press	2024-04-22 06:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com